Edition:
United States

Flex Pharma Inc (FLKS.OQ)

FLKS.OQ on NASDAQ Stock Exchange Global Market

3.54USD
11 Dec 2017
Change (% chg)

$-0.18 (-4.84%)
Prev Close
$3.72
Open
$3.72
Day's High
$3.72
Day's Low
$3.54
Volume
4,115
Avg. Vol
9,451
52-wk High
$6.46
52-wk Low
$2.68

Select another date:

Tue, Nov 28 2017

BRIEF-Flex Pharma Inc - ‍Completed Enrollment In Its Phase 2 Exploratory Spasticity Study In Multiple Sclerosis With Approximately 50 Patients In Australia​

* FLEX PHARMA INC - ‍COMPLETED ENROLLMENT IN ITS PHASE 2 EXPLORATORY SPASTICITY STUDY IN MULTIPLE SCLEROSIS WITH APPROXIMATELY 50 PATIENTS IN AUSTRALIA​ Source text for Eikon: Further company coverage:

BRIEF-Flex Pharma Q3 loss per share $0.54

* Q3 earnings per share view $-0.61 -- Thomson Reuters I/B/E/S

BRIEF-Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS

* Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS

BRIEF-Flex Pharma initiates CMT phase 2 trial with FLX-787 in US

* Flex Pharma Inc - ‍expects to report topline results from this study in middle of 2018​ Source text for Eikon: Further company coverage:

BRIEF-Flex Pharma says on Aug 23, board unanimously voted to increase the size of co's board of directors to nine members ‍​- SEC filing

* Flex Pharma says on Aug 23, board unanimously voted to increase the size of co's board of directors to nine members ‍​- SEC filing

BRIEF-Flex Pharma Q2 loss per share $0.51

* Q2 earnings per share view $-0.58 -- Thomson Reuters I/B/E/S

BRIEF-Flex Pharma initiates ALS phase 2 trial with flx-787 in U.S.

* Says expects to report topline results from this study in middle of 2018

BRIEF-Flex Pharma names William Mcvicar president and chief executive officer

* Flex pharma names William Mcvicar president and chief executive officer

BRIEF-FDA grants fast track designation to Flex Pharma’s FLX-787

* FDA grants fast track designation to Flex Pharma’s FLX-787 for the treatment of severe muscle cramps associated with ALS

Select another date: